Depressive Disorders - China | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$1.91bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.51%, resulting in a market volume of US$2.06bn by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$45.36 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in China has been experiencing significant growth in recent years. Customer preferences for mental health treatment have shifted towards seeking professional help and utilizing medication. This trend is driven by several factors, including increased awareness and understanding of mental health issues, changing societal attitudes towards mental health, and the availability of more treatment options.

Customer preferences: In the past, mental health issues were often stigmatized in Chinese society, leading many individuals to suffer in silence. However, there has been a notable shift in customer preferences, with more people now seeking professional help for depressive disorders. This change can be attributed to increased awareness and understanding of mental health issues, as well as a growing acceptance of seeking treatment. Customers are also increasingly open to using medication as part of their treatment plan, recognizing the benefits it can provide in managing depressive disorders.

Trends in the market: One of the key trends in the Depressive Disorders market in China is the growing demand for antidepressant medications. As more people seek professional help and are diagnosed with depressive disorders, the need for medication to manage symptoms has increased. This trend is also influenced by the availability of a wider range of antidepressant medications in the market, providing customers with more options to choose from.Another trend in the market is the rise of online mental health platforms and telemedicine services. These platforms provide convenient and accessible ways for individuals to seek professional help for their depressive disorders. With the increasing use of smartphones and internet connectivity in China, online mental health platforms have become popular among customers who prefer the convenience and privacy they offer.

Local special circumstances: China's large population and rapid urbanization have contributed to the growth of the Depressive Disorders market. The fast-paced and competitive nature of urban life, coupled with the pressure to succeed, has led to an increase in mental health issues among the population. This has created a significant market opportunity for mental health professionals and pharmaceutical companies to meet the growing demand for treatment.

Underlying macroeconomic factors: China's economic growth and rising disposable incomes have also played a role in the development of the Depressive Disorders market. As people become more financially stable, they are more willing to invest in their mental health and seek professional treatment. Additionally, the government's increased focus on mental health and the inclusion of mental health services in public healthcare coverage have further contributed to the growth of the market.In conclusion, the Depressive Disorders market in China is experiencing growth due to changing customer preferences, increased awareness of mental health issues, and the availability of more treatment options. The demand for antidepressant medications and online mental health platforms is on the rise, driven by a growing acceptance of seeking professional help and the convenience they offer. China's large population, rapid urbanization, and improving economic conditions have created a favorable environment for the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.